FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:1968-1971 November 8, 2007 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Fermé, C. PubMed Citation

The history of Hodgkin's disease is one of the most exciting stories in medicine. The disorder accounts for about 1% of all cancers and is curable in 85 to 95% of cases, depending on its stage — whether it is localized or disseminated. Indeed, the article by Fermé et al.¹ in this issue of the Journal reports on 10-year survival estimates of 97% for patients with early-stage disease.

In 1832, in an article entitled "On Some Morbid Appearances of the Absorbent Glands and Spleen,"² Thomas Hodgkin discussed six patients with symptoms that differed from those associated with inflammation, tuberculosis, and . . . [Full Text of this Article]

Related Letters:

Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's Disease
Olweny C. L.M., Ziegler J. L., Papac R. J., Subbiah V., Fermé C., Eghbali H., Henry-Amar M.
Extract | Full Text | PDF  
N Engl J Med 2008; 358:742-743, Feb 14, 2008. Correspondence

This article has been cited by other articles:

• Olweny, C. L.M., Ziegler, J. L., Papac, R. J., Subbiah, V., Ferme, C., Eghbali, H., Henry-Amar, M. (2008). Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.. NEJM 358: 742-743 [Full Text]